GB201800395D0 - Novel combination and use of antibodies - Google Patents

Novel combination and use of antibodies

Info

Publication number
GB201800395D0
GB201800395D0 GBGB1800395.4A GB201800395A GB201800395D0 GB 201800395 D0 GB201800395 D0 GB 201800395D0 GB 201800395 A GB201800395 A GB 201800395A GB 201800395 D0 GB201800395 D0 GB 201800395D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
novel combination
novel
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1800395.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southampton
Bioinvent International AB
Original Assignee
University of Southampton
Bioinvent International AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southampton, Bioinvent International AB filed Critical University of Southampton
Priority to US16/959,425 priority Critical patent/US20200362036A1/en
Priority to GBGB1800395.4A priority patent/GB201800395D0/en
Publication of GB201800395D0 publication Critical patent/GB201800395D0/en
Priority to RU2020126449A priority patent/RU2800035C2/en
Priority to CA3088856A priority patent/CA3088856A1/en
Priority to AU2019207767A priority patent/AU2019207767A1/en
Priority to PCT/EP2019/050566 priority patent/WO2019138005A2/en
Priority to BR112020013925-4A priority patent/BR112020013925A2/en
Priority to CN201980007995.5A priority patent/CN111683969A/en
Priority to KR1020207020738A priority patent/KR20200108286A/en
Priority to JP2020538137A priority patent/JP2021510299A/en
Priority to EP19701993.8A priority patent/EP3737698A2/en
Priority to MX2020007401A priority patent/MX2020007401A/en
Priority to JP2023203271A priority patent/JP2024026237A/en
Ceased legal-status Critical Current

Links

GBGB1800395.4A 2018-01-10 2018-01-10 Novel combination and use of antibodies Ceased GB201800395D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
US16/959,425 US20200362036A1 (en) 2018-01-10 2018-01-10 Novel combination and use of antibodies
GBGB1800395.4A GB201800395D0 (en) 2018-01-10 2018-01-10 Novel combination and use of antibodies
MX2020007401A MX2020007401A (en) 2018-01-10 2019-01-10 Novel combination and use of antibodies.
BR112020013925-4A BR112020013925A2 (en) 2018-01-10 2019-01-10 first antibody molecule, pharmaceutical composition, kit for use in the treatment of cancer negative for fc¿riib, use, and, method for treatment of cancer negative for fc¿riib.
CA3088856A CA3088856A1 (en) 2018-01-10 2019-01-10 Novel combination and use of antibodies
AU2019207767A AU2019207767A1 (en) 2018-01-10 2019-01-10 Novel combination and use of antibodies
PCT/EP2019/050566 WO2019138005A2 (en) 2018-01-10 2019-01-10 Novel combination and use of antibodies
RU2020126449A RU2800035C2 (en) 2018-01-10 2019-01-10 New antibody combination and its use
CN201980007995.5A CN111683969A (en) 2018-01-10 2019-01-10 Novel combinations and uses of antibodies
KR1020207020738A KR20200108286A (en) 2018-01-10 2019-01-10 Novel antibody combinations and uses
JP2020538137A JP2021510299A (en) 2018-01-10 2019-01-10 New combinations of antibodies and their use
EP19701993.8A EP3737698A2 (en) 2018-01-10 2019-01-10 Novel combination and use of antibodies
JP2023203271A JP2024026237A (en) 2018-01-10 2023-11-30 Novel combinations of antibodies and their uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1800395.4A GB201800395D0 (en) 2018-01-10 2018-01-10 Novel combination and use of antibodies

Publications (1)

Publication Number Publication Date
GB201800395D0 true GB201800395D0 (en) 2018-02-21

Family

ID=61190419

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1800395.4A Ceased GB201800395D0 (en) 2018-01-10 2018-01-10 Novel combination and use of antibodies

Country Status (1)

Country Link
GB (1) GB201800395D0 (en)

Similar Documents

Publication Publication Date Title
IL276731A (en) Anti-cd73 antibodies and methods of use thereof
SG11202010909RA (en) Anti-msr1 antibodies and methods of use thereof
PL3618863T3 (en) Anti-tigit antibodies and methods of use thereof
ZA201906730B (en) Anti-trem2 antibodies and methods of use thereof
IL278821A (en) Anti-sirpa antibodies and methods of use thereof
IL270214A (en) Anti-sortilin antibodies and methods of use thereof
IL277308A (en) Anti-hla-g antibodies and use thereof
IL279648A (en) Anti-sirp-beta1 antibodies and methods of use thereof
IL277212A (en) Anti-klk5 antibodies and methods of use
IL290741A (en) Anti-cd96 antibodies and methods of use thereof
SG11202108734VA (en) Anti-trem2 antibodies and methods of use thereof
IL289952A (en) Anti-ms4a4a antibodies and methods of use thereof
IL283884A (en) Anti-il-36 antibodies and methods of use thereof
IL280338A (en) Anti-siglec-5 antibodies and methods of use thereof
IL285401A (en) Anti-clec2d antibodies and methods of use thereof
IL274221A (en) Anti-apoc3 antibodies and methods of use thereof
IL291461A (en) Anti-alpha-synuclein antibodies and methods of use thereof
IL279227A (en) Anti-siglec-7 antibodies and methods of use thereof
EP4061848A4 (en) Anti-ror-2 antibodies and methods of use
IL288886A (en) Antibodies and methods of use
GB201800461D0 (en) Novel combination and use of antibodies
GB201800395D0 (en) Novel combination and use of antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)